MAGLUMI
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

MAGLUMI Trademark

Serial Number: 79139817 • Registration: 4683169

MAGLUMI is a trademark filed by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. on July 17, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. (27 trademarks)

21st Floor, Snibe Building,

Entity Type: 99

Trademark Details

Filing Date

July 17, 2013

Registration Date

February 10, 2015

Published for Opposition

November 25, 2014

Goods & Services

Blood testing apparatus; [ massage apparatus; ] apparatus for use in medical analysis, namely, medical analyzer for analysis of blood samples, body fluids and body tissue samples; testing apparatus for medical purposes, namely, medical testing instrument for testing blood samples, body fluids and body tissue samples; diagnostic apparatus for medical purposes, namely, medical diagnostic analyzer for analyzing blood samples, body fluids and body tissue samples; radiotherapy apparatus; ultrasonic devices and parts thereof for medical use, namely, clinical ultrasonic diagnostic apparatus and parts thereof [ ; artificial limbs; multifunction corsets for medical purpose, namely, diagnosis and therapeutic corsets for medical purpose; suture materials ]

Drugs for medical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin disease; medicated serums for invitro diagnosis and treatment; medicated serums for in-vivo diagnosis and treatment; serotherapeutic medicines; cultures of microorganisms for medical and veterinary use; biological preparations for pharmaceutical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; chemical preparations for pharmaceutical purposes, namely, for diagnosis or treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; Diagnostic preparations for medical purposes, namely, for diagnosing or detecting tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; enzymes for medical purposes; enzyme preparations for medical purposes; chemical preparations for the diagnosis of pregnancy

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2026 NREP
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 19, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 19, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
May 19, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 19, 2025 APRE
TEAS SECTION 71 RECEIVED
Jan 24, 2025 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Feb 10, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
May 12, 2023 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Apr 12, 2023 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Feb 22, 2023 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 22, 2023 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 2, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 2, 2022 NA71
REGISTERED-SEC.71 ACCEPTED
May 2, 2022 71AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Nov 19, 2021 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Oct 27, 2021 PR71
POST REGISTRATION ACTION MAILED - SEC.71
Oct 25, 2021 PR71
REINSTATED
Oct 25, 2021 REIN
NOTICE OF CANCELLATION SEC. 71 E-MAILED
Oct 16, 2021 NC71
CANCELLED SECTION 71
Oct 15, 2021 C71T
POST REGISTRATION ACTION MAILED - SEC.71
Mar 11, 2021 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 4, 2021 APRE
TEAS SECTION 71 RECEIVED
Feb 7, 2021 ES71
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 20, 2020 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 26, 2015 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 27, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 11, 2015 FICS
FINAL DISPOSITION PROCESSED
Jun 11, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 10, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2015 R.PR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jan 13, 2015 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Jan 3, 2015 CRCV
PUBLISHED FOR OPPOSITION
Nov 25, 2014 PUBO
NOTICE OF PUBLICATION
Nov 5, 2014 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 23, 2014 PREV
EXAMINERS AMENDMENT MAILED
Oct 22, 2014 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 22, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 22, 2014 XAEC
EXAMINERS AMENDMENT -WRITTEN
Oct 22, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 13, 2014 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 13, 2014 ERFR
FINAL REFUSAL MAILED
May 27, 2014 CNFR
FINAL REFUSAL WRITTEN
May 26, 2014 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 17, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2014 CRFA
ASSIGNED TO LIE
Apr 8, 2014 ALIE
ASSIGNED TO LIE
Mar 28, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 17, 2014 TROA
REFUSAL PROCESSED BY IB
Jan 17, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 30, 2013 RFCS
REFUSAL PROCESSED BY MPU
Dec 30, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 21, 2013 RFCR
NON-FINAL ACTION WRITTEN
Dec 20, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 18, 2013 MAFR
ASSIGNED TO EXAMINER
Dec 14, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 14, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 12, 2013 REPR